Providing Today's Patients with Medicines of the Future.
Staff
2017-2019 Net Profit CAGR
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions
NANJING, China, March 29, 2021 –, Simcere Pharmaceutical Group Ltd (HKSE: 2096), today announces that its affiliate entered into an exclusive license ...
October 27, 2020 - Simcere Pharmaceutical Group Limited (2096.HK) announced today that the company has officially been listed on the Hong Kong Stock...
- Simcere to lead clinical development, regulatory submissions and commercialization of trilaciclib across all indications in Greater China - G1 to re...
On May 18, 2020, Simcere announced the collaboration with Primary Peptides, a privately held biotech company in Canada, on exclusive license to develo...